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bnormality had surgery under general anaesthetic. No patient
equired cardiac surgery or balloon angioplasty pre-operatively.
atients having pre-operative echo had signiﬁcant delay to surgery
average 2.7 days, range 0–6 days) compared to ‘non-echo’ group
average 1.1 days, range 0–3 days) (P< .001). There was no signiﬁ-
ant difference in length of stay and mortality at 28 days between
he groups. We are now developing departmental guidelines for
equesting echo in hip fracture patients with cardiac murmur to
revent unnecessary avoidable delay, and plan to re-audit.
oi:10.1016/j.injury.2010.07.334
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otal hip replacement in acute displaced intracapsular proxi-
al femoral fractures—the role of large diameter heads & their
ffect on dislocation rates
. Cox, S. Kazzaz, M. Deakin
Department of Trauma Surgery, John Radcliffe Hospital, Headley Way,
eadington, Oxford, United Kingdom
Introduction: Current literature supports the use of total hip
eplacement (THR) for the treatment of displaced intra-capsular
roximal femoral fractures (DIPFF). Case series of patients receiving
his treatment show dislocation rates higher than that of patients
ho have THR to treat osteoarthritis. Large diameter THR have
echanical advantages in terms of dislocation and their role in
IPFF has yet to be assessed.
Objectives: To assess the role of large diameter THR on the rate
f dislocation when used to treat DIPFF.
Design: Single surgeon, case series.
Level of evidence: Level IV.
Setting: Level I trauma centre.
Inclusion criteria:
1) Displaced intra-capsular proximal femoral fracture (Garden III
& IV).
2) Age >65 years.
3) Independently mobile pre-operatively for distances greater
than a mile, with no more than 1 stick as a mobility aid.
4) Abbreviated mental test score of 9/10 or greater.
Exclusion criteria:
1) Pathological fractures.
2) Additional fractures of the femur.
Outcomes:
1) Mortality & Morbidity.
2) Dislocation rate.
Patients/Participants: Patients who presented between May
006 and December 2008 and met the requirements had a col-
arless polished tapered (CPT®) (Zimmer) femoral stem cemented
2nd generation technique), Metasul® (Zimmer) large diameter
ead and uncementedDurom® (Zimmer) cup inserted as a primary
rocedure via a modiﬁed Hardinge technique. Follow up was via
outine clinic appointments, letter to GP and phone conversation
ith patient.
Results: 67 patients were selected (49 females) average age was
4.6 (67–87). Follow up was for an average of 14 months (3–39
onths). No dislocations or deaths were recorded for this period of
ime. One patient had aseptic loosening of the acetabular compo-
ent and twopatients sustainedperi-prosthetic fractures following
alls (Vancouver B)—these cases were revised successfully.
Conclusions: This study suggests that the high rates of disloca-
ion associated with THR for PPF can be limited by the use of large
iameter components. This study should be followed by a multi-
entre multi-surgeon study.1 (2010) 167–196 171
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Anticoagulation management in patient undergoing elective
and emergency orthopaedic procedures
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Introduction: Warfarin is an oral anticoagulant which antago-
nises the effects of vitamin K. Warfarin remains the treatment of
choice for the majority of patients with venous thromboembolism,
atrial ﬁbrillation and valvular heart disease or valve replacement
unless contraindicated. Careful monitoring of international nor-
malised ratio (INR) is indicated during period of treatment. Poor
management of patients onwarfarin often leads to delay in surgery,
life threatening bleeding during or after operation and unnecessary
delay in discharge from hospitals in United Kingdom.
Methods: We carried out a prospective study on patients
who were on warfarin and underwent elective and emergency
orthopaedic procedures during period of study – August 2007
to April 2008. All patients included in the study were identiﬁed
from admission notes during period of study. All data regarding
indications for warfarin, pre and post procedures INR, elective or
emergency orthopaedic procedures and complications were col-
lected using a standard proforma.
Results: 18 patients, 12 male and 6 female were included into
the study. Patients’ age ranged from 47 to 87 with mean of 76.
The indications for warfarin therapy were atrial ﬁbrillation in 12
patients, deep vein thrombosis in 5 patients and left ventricular
aneurysm in 1 patient. 18 procedures, 10 elective and 8 emergency
orthopaedic procedures were carried out during period of study.
Elective procedures – 7 primary joint arthroplasty, 1 revision hip
arthroplasty, 1 removal of metalwork and 1 metatarsophalangeal
joint fusion. Emergency procedures – 4 hip hemiarthroplasty, 2
dynamic hip screw ﬁxation, 1 external ﬁxator application and 1
open reduction and internal ﬁxation of ankle. All elective admis-
sion patients were pre-assessed in clinic prior to admission and
were advised to stop warfarin based on their INR level. Patients
with INR 2–3 had their warfarin stopped 4 days prior to surgery
while patients with INR 3–4.5 had their warfarin stopped 5 days
prior to surgery. This group of patients had their INR check on
admission and ranged from 1.1 to 1.5. This group of patients
had no reversal therapy and no cancellations were made to their
operation. 8 emergency admission patients had INR of 1.4–4.7
on admission with mean of 2.7. 5 patients had reversal therapy
while 3 patients had no reversal therapy. Pharmacological meth-
ods used to reduce the INR were fresh frozen plasma in 1 patient
and Vitamin K in 4 other patients. 2 patients that received rever-
sal therapy had operation on day 1, 2 on day 3 and 1 on day 5.
1 patient that had no reversal therapy was operated on day 1, 1
on day 3 and 1 on day 5. Patient that received no reversal ther-
apy and operated on day 5 of admission died post-operatively
frommedical complications.Mean delay for patient that had rever-
sal therapy was 2.2 days compared to 3 days in patient with
no reversal therapy. All patients in this study had prophylactic
low molecular weight heparin while off warfarin. Patients were
recommenced on their normal dose of warfarin the day after their
operation. 1 patient in the emergency admission group had INR
